Submissions from 2024
Combination biologics or targeted synthetic disease-modifying anti-rheumatic drugs in the treatment of spondyloarthritis: a systematic literature review., Rand Abedalweli, Michelle Nguyen, and Atul Deodhar
Evaluating the fairness and accuracy of machine learning-based predictions of clinical outcomes after anatomic and reverse total shoulder arthroplasty., Christine Allen, Vikas Kumar, Josie Elwell, Steven Overman, Bradley S Schoch, William Aibinder, Moby Parsons, Jonathan Watling, Jiawei Kevin Ko, Bruno Gobbato, Thomas Throckmorton, Howard Routman, and Christopher P Roche
Are insufficient corrections a major factor in distal junctional kyphosis? A simulated analysis of cervical deformity correction using in-construct measurements., Fares Ani, Ethan Sissman, Dainn Woo, Alex Soroceanu, Gregory Mundis, Robert K Eastlack, Justin S Smith, D Kojo Hamilton, Han Jo Kim, Alan H Daniels, Eric O Klineberg, Brian Neuman, Daniel M Sciubba, Munish C Gupta, Khaled M Kebaish, Peter G Passias, Robert A Hart, Shay Bess, Christopher I Shaffrey, Frank J Schwab, Virginie Lafage, Christopher P Ames, and Themistocles S Protopsaltis
GRAPPA 2023: Major Projects, Key Advances, and Milestones., Gizem Ayan, Sibel Z Aydin, Laura C Coates, Lihi Eder, Dafna D Gladman, Philip S Helliwell, Gurjit S Kaeley, Arthur Kavanaugh, Philip J Mease, Stephen R Pennington, Fabian Proft, Enrique R Soriano, and Oliver FitzGerald
Stronger association of objective physical metrics with baseline patient-reported outcome measures than preoperative standing sagittal parameters for adult spinal deformity patients., Tej D Azad, Frank J Schwab, Virginie Lafage, Alex Soroceanu, Robert K Eastlack, Renaud Lafage, Khaled M Kebaish, Robert A Hart, Bassel Diebo, Michael P Kelly, Justin S Smith, Alan H Daniels, D Kojo Hamilton, Munish Gupta, Eric O Klineberg, Themistocles S Protopsaltis, Peter G Passias, Shay Bess, Jeffrey L Gum, Richard Hostin, Stephen J Lewis, Christopher I Shaffrey, Douglas Burton, Lawrence G Lenke, Christopher P Ames, and Justin K Scheer
BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studies., Xenofon Baraliakos, Dafna D Gladman, Soumya D Chakravarty, Cinty Gong, May Shawi, Emmanouil Rampakakis, Mitsumasa Kishimoto, Enrique R Soriano, and Philip Mease
Safety and real-world dosing of onabotulinumtoxinA for the treatment of adult spasticity: post hoc analysis of the Adult Spasticity International Registry study., Ganesh Bavikatte, Alberto Esquenazi, Michael A Dimyan, Khashayar Dashtipour, Wuwei Feng, Angeli Mayadev, Kristina Fanning, Tiziana Musacchio, Aleksej Zuzek, and Gerard E Francisco
Improving the nosology of Long COVID: it is not so simple., Leonard H Calabrese and Philip Mease
Intraoperative fluid management in adult spinal deformity surgery: variation analysis and association with outcomes., Riza M Cetik, Jeffrey L Gum, Renaud Lafage, Justin S Smith, Shay Bess, Jeffrey P Mullin, Michael P Kelly, Bassel G Diebo, Thomas J Buell, Justin K Scheer, Breton G Line, Virginie Lafage, Eric O Klineberg, Han Jo Kim, Peter G Passias, Khaled M Kebaish, Robert K Eastlack, Alan H Daniels, Alex Soroceanu, Gregory M Mundis, Richard A Hostin, Themistocles S Protopsaltis, D Kojo Hamilton, Robert A Hart, Munish C Gupta, Stephen J Lewis, Frank J Schwab, Lawrence G Lenke, Christopher I Shaffrey, Christopher P Ames, Douglas C Burton, and International Spine Study Group
GRAPPA 2023 Collaborative Research Network Meeting., Vinod Chandran, Dafna D Gladman, Philip J Mease, Lihi Eder, Stephen R Pennington, Oliver FitzGerald, Christopher Ritchlin, Dan E Webster, Kurt de Vlam, and Wilson Liao
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study., Laura C Coates, Laure Gossec, Miriam Zimmermann, May Shawi, Emmanouil Rampakakis, Natalie J Shiff, Alexa P Kollmeier, Xie L Xu, Peter Nash, Philip J Mease, and Philip S Helliwell
Continuous improvement through differential trajectories of individual minimal disease activity criteria with guselkumab in active psoriatic arthritis: post hoc analysis of a phase 3, randomized, double-blind, placebo-controlled study., Laura C Coates, Proton Rahman, Philip J Mease, May Shawi, Emmanouil Rampakakis, Alexa P Kollmeier, Xie L Xu, Soumya D Chakravarty, Iain B McInnes, and Lai-Shan Tam
Predictors of pelvic tilt normalization: a multicenter study on the impact of regional and lower-extremity compensation on pelvic alignment after complex adult spinal deformity surgery., Pooja Dave, Renaud Lafage, Justin S Smith, Breton G Line, Peter S Tretiakov, Jamshaid Mir, Bassel Diebo, Alan H Daniels, Jeffrey L Gum, D Kojo Hamilton, Thomas Buell, Khoi D Than, Kai-Ming Fu, Justin K Scheer, Robert Eastlack, Jeffrey P Mullin, Gregory Mundis, Naobumi Hosogane, Mitsuru Yagi, Pierce Nunley, Dean Chou, Praveen V Mummaneni, Eric O Klineberg, Khaled M Kebaish, Stephen Lewis, Richard A Hostin, Munish C Gupta, Han Jo Kim, Christopher P Ames, Robert A Hart, Lawrence G Lenke, Christopher I Shaffrey, Shay Bess, Frank J Schwab, Virginie Lafage, Douglas C Burton, and Peter G Passias
A secukinumab dose-escalation study in patients with ankylosing spondylitis not achieving inactive disease after 16 weeks of treatment., Atul Deodhar, Alan J Kivitz, Marina Magrey, Jessica A Walsh, Philip J Mease, Maria Greenwald, Farid Kianifard, Chelsea Elam, Gopi M Bommidi, Adam Winseck, and Lianne S Gensler
Correction: Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial., Kurt de Vlam, Walter P Maksymowych, Gaia Gallo, Proton Rahman, Philip Mease, Venkatesh Krishnan, Conor J McVeigh, Jeffrey Lisse, Danting Zhu, Rebecca J Bolce, and Philip G Conaghan
Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial., Kurt de Vlam, Walter P Maksymowych, Gaia Gallo, Proton Rahman, Philip Mease, Venkatesh Krishnan, Conor J McVeigh, Jeffrey Lisse, Danting Zhu, Rebecca J Bolce, and Philip G Conaghan
Hip Osteoarthritis in Patients Undergoing Surgery for Severe Adult Spinal Deformity: Prevalence and Impact on Spine Surgery Outcomes., Bassel G Diebo, Daniel Alsoof, Mariah Balmaceno-Criss, Mohammad Daher, Renaud Lafage, Peter G Passias, Christopher P Ames, Christopher I Shaffrey, Douglas C Burton, Vedat Deviren, Breton G Line, Alex Soroceanu, D Kojo Hamilton, Eric O Klineberg, Gregory M Mundis, Han Jo Kim, Jeffrey L Gum, Justin S Smith, Juan S Uribe, Khaled M Kebaish, Munish C Gupta, Pierce D Nunley, Robert K Eastlack, Richard Hostin, Themistocles S Protopsaltis, Lawrence G Lenke, Robert A Hart, Frank J Schwab, Shay Bess, Virginie Lafage, and Alan H Daniels
Cannabis Use Disorder Trends and Health Care Utilization After Cervical and Lumbar Spine Fusions., Nicholas Dietz, Victoria Alkin, Nitin Agarwal, Mayur Sharma, Brent Garrison Oxford, Dengzhi Wang, Beatrice Ugiliweneza, Jersey Mettille, Maxwell Boakye, and Doniel Drazin
Elective Single-Level Primary Anterior Cervical Decompression and Fusion for Degenerative Spondylotic Cervical Myelopathy is Associated With Decreased Resource Utilization Versus Posterior Cervical Decompression and Fusion., Jerry Y Du, Karim Shafi, Collin W Blackburn, Jens R Chapman, Nicholas U Ahn, Randall E Marcus, and Todd J Albert
Resource Utilization following Anterior Versus Posterior Cervical Decompression and Fusion for Acute Central Cord Syndrome., Jerry Y Du, Karim Shafi, Collin W Blackburn, Jens R Chapman, Nicholas U Ahn, Randall E Marcus, and Todd J Albert
Comment on: Effect of gender and age on bDMARD efficacy for axial spondyloarthritis patients: a meta-analysis of randomized controlled trials., Lihi Eder, Jordi Pardo Pardo, Philip Mease, and Lianne S Gensler
Phase 2 Trial of Deucravacitinib in Psoriatic Arthritis: Biomarkers Associated With Disease Activity, Pharmacodynamics, and Clinical Responses., Oliver FitzGerald, Dafna D Gladman, Philip Mease, Christopher Ritchlin, Josef S Smolen, Lu Gao, Yanhua Hu, Miroslawa Nowak, Subhashis Banerjee, and Ian Catlett
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Celebrates Its 20th Anniversary., Dafna D Gladman, Philip S Helliwell, and Philip J Mease
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update., Laure Gossec, Andreas Kerschbaumer, Ricardo J O Ferreira, Daniel Aletaha, Xenofon Baraliakos, Heidi Bertheussen, Wolf-Henning Boehncke, Bente Appel Esbensen, Iain B McInnes, Dennis McGonagle, Kevin L Winthrop, Andra Balanescu, Peter V Balint, Gerd R Burmester, Juan D Cañete, Pascal Claudepierre, Lihi Eder, Merete Lund Hetland, Annamaria Iagnocco, Lars Erik Kristensen, Rik Lories, Rubén Queiro, Daniele Mauro, Helena Marzo-Ortega, Philip Mease, Peter Nash, Wendy Wagenaar, Laura Savage, Georg Schett, Stephanie J W Shoop-Worrall, Yoshiya Tanaka, Filip E Van den Bosch, Annette van der Helm-van Mil, Alen Zabotti, Désirée van der Heijde, and Josef S Smolen
Bimekizumab provided rapid improvements in patient-reported symptoms and health-related quality of life in patients with active psoriatic arthritis: pooled 16-week results from two phase 3 studies., M Elaine Husni, Philip Mease, Joseph F Merola, William Tillett, Nadine Goldammer, Barbara Ink, Jason Coarse, Jérémy Lambert, Vanessa Taieb, and Dafna D Gladman
The Burden of Work Productivity and Activity Impairment in Patients with Psoriasis, Psoriatic Arthritis, Ulcerative Colitis, and Crohn's Disease., Jud C Janak, Anita M Loughlin, Page C Moore, Celeste A Lemay, Philip J Mease, Mark Lebwohl, Joshua R Korzenik, Raymond K Cross, and David Hudesman
Association Between Achievement of Clinical Disease Control and Improvement in Patient-Reported Outcomes and Quality of Life in Patients With Psoriatic Arthritis in the Phase 3 SELECT-PsA 1 and 2 Randomized Controlled Trials., Arthur Kavanaugh, Philip Mease, Laure Gossec, Roberto Ranza, Shigeyoshi Tsuji, Kevin Douglas, Michael Lane, Ralph Lippe, Manish Mittal, Tianming Gao, Arathi Setty, Sandra Ciecinski, Daniel Aletaha, and Peter Nash
Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices., Aliya A Khan, Riemer H J A Slart, Dalal S Ali, Oliver Bock, John J Carey, Pauline Camacho, Klaus Engelke, Paola A Erba, Nicholas C Harvey, Willem F Lems, Sarah Morgan, Kendall F Moseley, Christopher O'Brien, Linda Probyn, Marija Punda, Bradford Richmond, John T Schousboe, Christopher Shuhart, Kate A Ward, and E Michael Lewiecki
DXA Reporting Updates: 2023 Official Positions of the International Society for Clinical Densitometry., Diane Krueger, S Bobo Tanner, Auryan Szalat, Alan Malabanan, Tyler Prout, Adrian Lau, Harold N Rosen, and Christopher Shuhart
Reporting of Full-Length Femur Imaging to Detect Incomplete Atypical Femur Fractures: 2023 Official Positions of the International Society for Clinical Densitometry., Adrian Lau, Tyler Prout, Alan Malabanan, Auryan Szalat, Diane Krueger, S Bobo Tanner, Harold Rosen, and Christopher Shuhart
Beyond guesswork: how accurate are surgeons at determining the degree of glenoid bone loss in instability surgery?, Caleb A LaVigne, Timothy B Griffith, Zachary C Hanson, Donald D Davis, James S Kercher, and Xavier A Duralde
KIAA0753 enhances osteoblast differentiation suppressed by diabetes., Mengxue Li, Yongqin Wang, Xiangmei Wu, Quanmei Chen, Jianguo Huang, Huifang Zhu, Shengyong Yang, Jichun Wang, Le Tai Li, Xianjun Liu, Kang Fu, Fangzhou Song, and Changdong Wang
Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies., Iain B McInnes, Philip Mease, Yoshiya Tanaka, Laure Gossec, M Elaine Husni, Lars Erik Kristensen, Richard B Warren, Barbara Ink, Rajan Bajracharya, Jason Coarse, and Alice B Gottlieb
Effectiveness of bDMARDs in ankylosing spondylitis patients by biologic use: experience from the CorEvitas PsA/SpA Registry., Philip Mease, Taylor Blachley, William N Malatestinic, Leslie R Harrold, Blessing Dube, Jeffrey R Lisse, Rebecca J Bolce, and Theresa M Hunter
Comparative efficacy and safety of bimekizumab in psoriatic arthritis: a systematic literature review and network meta-analysis., Philip Mease, Dafna D Gladman, Joseph F Merola, Peter Nash, Stacy Grieve, Victor Laliman-Khara, Damon Willems, Vanessa Taieb, Adam R Prickett, and Laura C Coates
Navigating the complexity of pain in psoriatic arthritis and axial spondyloarthritis., Philip J Mease
Impact of Disease Factors of Patients with Psoriasis and Psoriatic Arthritis on Biologic Therapy Switching: Real-World Evidence from the CorEvitas Psoriasis Registry., Philip J Mease, Andrew Blauvelt, Adam P Sima, Silky W Beaty, Robert Low, Braulio Gomez, Marie Gurrola, and Mark G Lebwohl
Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies., Philip J Mease, Joseph F Merola, Yoshiya Tanaka, Laure Gossec, Iain B McInnes, Christopher T Ritchlin, Robert B M Landewé, Akihiko Asahina, Barbara Ink, Andrea Heinrichs, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, and Laura C Coates
Adherence, Persistence, Healthcare Resource Use, and Costs in Tofacitinib-Treated Patients with Psoriatic Arthritis: Data from Two United States Claims Databases., Philip J Mease, Eros Papademetriou, Ravi Potluri, Ekta Agarwal, Joseph C Cappelleri, and You-Li Ling
Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis., Philip J Mease, Soumya Reddy, Sarah Ross, Jeffrey R Lisse, Paulo Reis, Kirstin Griffing, Christophe Sapin, Aisha Vadhariya, and Daniel E Furst
Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison., Philip J Mease, Richard B Warren, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Vanessa Taieb, Jason Eells, and Iain B McInnes
Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison., Philip J Mease, Richard B Warren, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Damon Willems, Vanessa Taieb, Jason Eells, and Iain B McInnes
Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison., Philip J Mease, Richard B Warren, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Damon Willems, Vanessa Taieb, Jason Eells, and Iain B McInnes
Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison., Philip J Mease, Richard B Warren, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Damon Willems, Vanessa Taieb, Jason Eells, and Iain B McInnes
Guselkumab in Biologic-Naïve Patients with Active Psoriatic Arthritis in Russia: A Post Hoc Analysis of the DISCOVER-1 and -2 Randomized Clinical Trials., Philip Mease, Tatiana Korotaeva, Pavel Shesternya, Muza Kokhan, Anton Rukavitsyn, Dmitry Vasilchenkov, Mohamed Sharaf, Frédéric Lavie, and Atul Deodhar
Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry., Philip Mease, Alexis Ogdie, John Tesser, Natalie J Shiff, Ruizhi Sophia Zhao, Soumya D Chakravarty, Michael Kelleman, Rhiannon Dodge, Robert R McLean, Aaron Broadwell, Arthur Kavanaugh, and Joseph F Merola
Prevalence of Fibromyalgia and Widespread Pain in Psoriatic Arthritis: Association with Disease Severity Assessment in a Large US Registry., Philip Mease, George Reed, Alexis Ogdie, Dimitrios A Pappas, and Joel M Kremer
Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry., Philip Mease, Pamela Young, Lara Fallon, Rajiv Mundayat, Oluwaseyi Dina, Taylor Blachley, Nicole Middaugh, and Alexis Ogdie
Machine learning clustering of adult spinal deformity patients identifies four prognostic phenotypes: a multicenter prospective cohort analysis with single surgeon external validation., Sarthak Mohanty, Fthimnir M Hassan, Lawrence G Lenke, Erik Lewerenz, Peter G Passias, Eric O Klineberg, Virginie Lafage, Justin S Smith, D Kojo Hamilton, Jeffrey L Gum, Renaud Lafage, Jeffrey Mullin, Bassel Diebo, Thomas J Buell, Han Jo Kim, Khalid Kebaish, Robert Eastlack, Alan H Daniels, Gregory Mundis, Richard Hostin, Themistocles S Protopsaltis, Robert A Hart, Munish Gupta, Frank J Schwab, Christopher I Shaffrey, Christopher P Ames, Douglas Burton, Shay Bess, and International Spine Study Group
Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2., Victoria Navarro-Compán, Sofia Ramiro, Atul Deodhar, Philip Mease, Martin Rudwaleit, Christine de la Loge, Carmen Fleurinck, Vanessa Taieb, Michael F Mørup, Ute Massow, Jonathan Kay, and Marina Magrey
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who had inadequate efficacy and/or intolerance to one prior tumor necrosis factor inhibitor: study protocol for SOLSTICE, a phase 3B, multicenter, randomized, double-blind, placebo-controlled study., Alexis Ogdie, Joseph F Merola, Philip Mease, Christopher T Ritchlin, Jose U Scher, Kimberly Parnell Lafferty, Daphne Chan, Soumya D Chakravarty, Wayne Langholff, Yanli Wang, Olivia Choi, Yevgeniy Krol, and Alice B Gottlieb
Factors Associated with the Maintenance of Cost-Effectiveness at 5 Years in Adult Spinal Deformity Corrective Surgery., Peter G Passias, Jamshaid M Mir, Pooja Dave, Justin S Smith, Renaud Lafage, Jeffrey Gum, Breton G Line, Bassel Diebo, Alan H Daniels, David Kojo Hamilton, Thomas J Buell, Justin K Scheer, Robert K Eastlack, Jeffrey P Mullin, Gregory M Mundis, Naobumi Hosogane, Mitsuru Yagi, Andrew J Schoenfeld, Juan S Uribe, Neel Anand, Praveen V Mummaneni, Dean Chou, Eric O Klineberg, Khaled M Kebaish, Stephen J Lewis, Munish C Gupta, Han Jo Kim, Robert A Hart, Lawrence G Lenke, Christopher P Ames, Christopher I Shaffrey, Frank J Schwab, Virginie Lafage, Richard A Hostin, Shay Bess, Douglas C Burton, and International Spine Study Group
Development of a modified frailty index for adult spinal deformities independent of functional changes following surgical correction: a true baseline risk assessment tool., Peter G Passias, Katherine E Pierce, Jamshaid M Mir, Oscar Krol, Renaud Lafage, Virginie Lafage, Breton Line, Juan S Uribe, Richard Hostin, Alan Daniels, Robert Hart, Douglas Burton, Christopher Shaffrey, Frank Schwab, Bassel G Diebo, Christopher P Ames, Justin S Smith, Andrew J Schoenfeld, Shay Bess, and Eric O Klineberg
Patient-specific Cervical Deformity Corrections With Consideration of Associated Risk: Establishment of Risk Benefit Thresholds for Invasiveness Based on Deformity and Frailty Severity., Peter G Passias, Katherine E Pierce, Tyler K Williamson, Jordan Lebovic, Andrew J Schoenfeld, Renaud Lafage, Virginie Lafage, Jeffrey L Gum, Robert Eastlack, Han Jo Kim, Eric O Klineberg, Alan H Daniels, Themistocles S Protopsaltis, Gregory M Mundis, Justin K Scheer, Paul Park, Dean Chou, Breton Line, Robert A Hart, Douglas C Burton, Shay Bess, Frank J Schwab, Christopher I Shaffrey, Justin S Smith, and Christopher P Ames
Exploring the complexities of pain phenotypes: OMERACT 2023 chronic pain working group workshop., Tim Pickles, Mary Cowern, Robin Christensen, Sabrina M Nielsen, Lee S Simon, Caitlin M P Jones, Lara J Maxwell, Beverley Shea, Vibeke Strand, Zahi Touma, Karine Toupin-April, Philip Mease, and Ernest Choy
The Incremental Clinical Benefit of Adding Layers of Complexity to the Planning and Execution of Adult Spinal Deformity Corrective Surgery., Katherine E Pierce, Jamshaid M Mir, Pooja Dave, Renaud Lafage, Virginie Lafage, Paul Park, Pierce Nunley, Gregory Mundis, Jeffrey Gum, Peter Tretiakov, Juan Uribe, Richard Hostin, Robert Eastlack, Bassel Diebo, Han Jo Kim, Justin S Smith, Christopher P Ames, Christopher Shaffrey, Douglas Burton, Robert A Hart, Shay Bess, Eric Klineberg, Frank Schwab, Munish Gupta, D Kojo Hamilton, and Peter G Passias
Polyurethane: An Old Material for a New Generation of Antibiotic Spacer Implants., James W Pritchett
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis., Proton Rahman, Iain B McInnes, Atul Deodhar, Georg Schett, Philip Mease, May Shawi, Daniel J Cua, Jonathan P Sherlock, Alexa P Kollmeier, Xie L Xu, Shihong Sheng, Christopher T Ritchlin, and Dennis McGonagle
Deciphering difficult-to-treat psoriatic arthritis (D2T-PsA): a GRAPPA perspective from an international survey of healthcare professionals., Andre L Ribeiro, Shikha Singla, Vinod Chandran, Nicholas Chronis, Wilson Liao, Christine Lindsay, Enrique R Soriano, Philip Mease, and Fabian Proft
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study., Christopher T Ritchlin, Philip Mease, Wolf-Henning Boehncke, John Tesser, Soumya D Chakravarty, Emmanouil Rampakakis, May Shawi, Elena Schiopu, Joseph F Merola, Iain B McInnes, and Atul Deodhar
Reporting Fewer Than Four Vertebrae: 2023 Official Positions of the International Society for Clinical Densitometry., Harold Rosen, Adrian Lau, Auryan Szalat, S Bobo Tanner, Diane Krueger, Tyler Prout, Alan Malabanan, and Christopher Shuhart
Executive Summary of the 2023 Adult Position Development Conference of the International Society for Clinical Densitometry: DXA Reporting, Follow-up BMD Testing and Trabecular Bone Score Application and Reporting., Christopher Shuhart, Angela Cheung, Ranjodh Gill, Linsey Gani, Heenam Goel, and Auryan Szalat
Modulation of IL-23 Signaling With Guselkumab in Biologic-Naïve Patients Versus TNF Inhibitor-Inadequate Responders With Active Psoriatic Arthritis., Stefan Siebert, Laura C Coates, Georg Schett, Siba P Raychaudhuri, Warner Chen, Sheng Gao, Loqmane Seridi, Soumya D Chakravarty, May Shawi, Frederic Lavie, Mohamed Sharaf, Miriam Zimmermann, Alexa P Kollmeier, Xie L Xu, Proton Rahman, Philip J Mease, and Atul Deodhar
Difficult-to-treat psoriatic arthritis (D2T PsA): a scoping literature review informing a GRAPPA research project., Shikha Singla, Andre Ribeiro, Murat Torgutalp, Philip Mease, and Fabian Proft
Improvements in patient-reported outcomes after treatment with deucravacitinib in patients with psoriatic arthritis: results from a randomized phase 2 trial., Vibeke Strand, Laure Gossec, Laura C Coates, Alexis Ogdie, Jiyoon Choi, Brandon Becker, Joe Zhuo, Thomas Lehman, Miroslawa Nowak, Ayanbola Elegbe, Philip Mease, and Atul Deodhar
Safety of Secukinumab from 1 Million Patient-Years of Exposure: Experience from Post-Marketing Setting and Clinical Trials., Rui Sun, Mercedes Bustamante, Venkatesh Kumar Gurusamy, Mark Lebwohl, Alice B Gottlieb, Philip Mease, Atul Deodhar, Weibin Bao, Meryl Mendelson, Brian Porter, Deepa Chand, and Victor Dong
Bilateral hip DXA Reporting: 2023 Official Positions of the International Society for Clinical Densitometry., S Bobo Tanner, Diane Krueger, Auryan Szalat, Tyler Prout, Adrian Lau, Alan Malabanan, Harold Rosen, and Christopher Shuhart
Historical Perspectives on the Evolution of Spino-Pelvic Fixation and its Implications on Clinical Care A Narrative Review., Alexander von Glinski, Emre Yilmaz, Periklis Godolias, Lorin Benneker, F C Oner, Frank Kandziora, Gregory Schroeder, Klaus Schnake, Marcel Dvorak, Shanmuganathan Rajasekaran, Mohammad El-Sharkawi, Alexander Vaccaro, Richard Bransford, Thomas A Schildhauer, and Jens R Chapman
Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors., Jessica A Walsh, Iris Lin, Ruizhi Zhao, Natalie J Shiff, Laura Morrison, Bruno Emond, Louise H Yu, Samuel Schwartzbein, Patrick Lefebvre, Dominic Pilon, Soumya D Chakravarty, and Philip Mease
Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison., Richard B Warren, Iain B McInnes, Peter Nash, Jean-Marie Grouin, Nikos Lyris, Damon Willems, Vanessa Taieb, Jason Eells, and Philip Mease
Persistent Lower Extremity Compensation for Sagittal Imbalance After Surgical Correction of Complex Adult Spinal Deformity: A Radiographic Analysis of Early Impact., Tyler K Williamson, Pooja Dave, Jamshaid M Mir, Justin S Smith, Renaud Lafage, Breton Line, Bassel G Diebo, Alan H Daniels, Jeffrey L Gum, Themistocles S Protopsaltis, D Kojo Hamilton, Alex Soroceanu, Justin K Scheer, Robert Eastlack, Michael P Kelly, Pierce Nunley, Khaled M Kebaish, Stephen Lewis, Lawrence G Lenke, Richard A Hostin, Munish C Gupta, Han Jo Kim, Christopher P Ames, Robert A Hart, Douglas C Burton, Christopher I Shaffrey, Eric O Klineberg, Frank J Schwab, Virginie Lafage, Dean Chou, Kai-Ming Fu, Shay Bess, Peter G Passias, and International Spine Study Group
Submissions from 2023
Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons., Nurullah Akkoç, Carlos H Arteaga, Simone E Auteri, Marissa Betts, Kyle Fahrbach, Mindy Kim, Sandeep Kiri, Binod Neupane, Karl Gaffney, and Philip J Mease
Determining the best vertebra for measuring pelvic incidence and spinopelvic parameters in adult spinal deformity patients with transitional anatomy., Fares Ani, Themistocles S Protopsaltis, Yesha Parekh, Khalid Odeh, Renaud Lafage, Justin S Smith, Robert K Eastlack, Lawrence Lenke, Frank Schwab, Gregory M Mundis, Munish C Gupta, Eric O Klineberg, Virginie Lafage, Robert A Hart, Douglas Burton, Christopher P Ames, Christopher I Shaffrey, and Shay Bess
Patient clusters identified by machine learning from a pooled analysis of the clinical development programme of secukinumab in psoriatic arthritis, ankylosing spondylitis and psoriatic arthritis with axial manifestations., Xenofon Baraliakos, Effie Pournara, Laura C Coates, Philip Mease, Samad S Jahandideh, and Dafna D Gladman
Would you do it again? Discrepancies between patient and surgeon perceptions following adult spine deformity surgery., Shay Bess, Breton Line, Christopher Ames, Douglas Burton, Gregory Mundis, Robert Eastlack, Robert A Hart, Munish Gupta, Eric Klineberg, Han Jo Kim, Richard Hostin, Khaled Kebaish, Virgine Lafage, Renaud Lafage, Frank Schwab, Christopher Shaffrey, and Justin S Smith
Postoperative Discharge to Acute Rehabilitation or Skilled Nursing Facility Compared to Home Does Not Reduce Hospital Readmissions, Return to Surgery or Improve Outcomes Following Adult Spine Deformity Surgery., Shay Bess, Breton G Line, Pierce Nunley, Christopher Ames, Douglas Burton, Gregory Mundis, Robert Eastlack, Robert A Hart, Munish Gupta, Eric Klineberg, Han Jo Kim, Michael Kelly, Richard Hostin, Khaled Kebaish, Virgine Lafage, Renaud Lafage, Frank Schwab, Christopher Shaffrey, Justin S Smith, and International Spine Study Group
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis., Gerd R Burmester, Stanley B Cohen, Kevin L Winthrop, Peter Nash, Alan D Irvine, Atul Deodhar, Eduardo Mysler, Yoshiya Tanaka, John Liu, Ana P Lacerda, Hannah Palac, Tim Shaw, Philip J Mease, and Emma Guttman-Yassky
Secukinumab improves physical function and quality of life and inhibits structural damage in patients with PsA with sustained remission or low disease activity: results from the 2-year phase 3 FUTURE 5 study., Laura C Coates, Philip Mease, Dafna D Gladman, Sandra Navarra, Weibin Bao, and Corine Gaillez
Longitudinal Assessment of Modern Spine Surgery Training: 10-Year Follow-up of a Nationwide Survey of Residency and Spine Fellowship Program Directors., Alan H Daniels, Daniel Alsoof, Christopher L McDonald, Andrew S Zhang, Bassel G Diebo, Craig P Eberson, Eren O Kuris, William Lavelle, Christopher P Ames, Christopher I Shaffrey, and Robert A Hart
Height Gain Following Correction of Adult Spinal Deformity., Bassel G Diebo, Zachary L Tataryn, Daniel Alsoof, Renaud Lafage, Robert A Hart, Peter G Passias, Christopher P Ames, Justin K Scheer, Stephen J Lewis, Christopher I Shaffrey, Douglas C Burton, Vedat Deviren, Breton G Line, Alex Soroceanu, D Kojo Hamilton, Eric O Klineberg, Gregory M Mundis, Han Jo Kim, Jeffrey L Gum, Justin S Smith, Juan S Uribe, Michael P Kelly, Khaled M Kebaish, Munish C Gupta, Pierce D Nunley, Robert K Eastlack, Richard Hostin, Themistocles S Protopsaltis, Lawrence G Lenke, Frank J Schwab, Shay Bess, Virginie Lafage, and Alan H Daniels
Impact of Race/Ethnicity on Hospital Resource Utilization After Elective Anterior Cervical Decompression and Fusion for Degenerative Myelopathy., Jerry Y Du, Collin W Blackburn, Jens R Chapman, Nicholas U Ahn, and Randall E Marcus
Registry Data Show Complication Rates and Cost in Revision Hip Arthroplasty., Paul J Duwelius, Richard D Southgate, James P Crutcher, Genevieve M Rollier, Hsin-Fang Li, Katie S Sypher, and Geoffrey S Tompkins
Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension., Lihi Eder, Dafna D Gladman, Philip Mease, Remy A Pollock, Rayana Luna, Sibel Z Aydin, Alexis Ogdie, Ari Polachek, David Gruben, Mary Jane Cadatal, Cassandra Kinch, and Vibeke Strand
Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and meta-analysis., Lihi Eder, Sivakami Mylvaganam, Jordi Pardo Pardo, Jennifer Petkovic, Vibeke Strand, Philip Mease, and Keith Colaco
Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced Therapy., A Mark Fendrick, Philip Mease, Matthew Davis, Pankaj Patel, Wes Matthias, Dominic Nunag, and Manish Mittal
Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, placebo-controlled study of biologic-naïve patients with active psoriatic arthritis., Alice B Gottlieb, Iain B McInnes, Proton Rahman, Alexa P Kollmeier, Xie L Xu, Yusang Jiang, Shihong Sheng, May Shawi, Soumya D Chakravarty, Frederic Lavie, and Philip J Mease
Three-Month Complication Rate of Ultrasound-Guided Soft Tissue Surgical Procedures Across Six Sports Medicine Clinics., Mederic M Hall, Stephanie A Kliethermes, P Troy Henning, Douglas F Hoffman, Kenneth Mautner, Ezi Obunadike, Kentaro Onishi, Adam M Pourcho, Jacob L Sellon, and Ruth Chimenti
Surgical stabilization of multiple rib fractures in an Asian population: a systematic review and meta-analysis., Weiwei He, Yi Yang, Raymark Salonga, Ledford Powell, Patrick Greiffenstein, Jonne T H Prins, and Stephen Patrick Abella
DXA Reporting Updates: 2023 Official Positions of the International Society for Clinical Densitometry., Diane Krueger, S Bobo Tanner, Auryan Szalat, Alan Malabanan, Tyler Prout, Adrian Lau, Harold N Rosen, and Christopher Shuhart
Reporting of full-length femur imaging to detect incomplete atypical femur fractures: 2023 Official Positions of the International Society for Clinical Densitometry., Adrian Lau, Tyler Prout, Alan Malabanan, Auryan Szalat, Diane Krueger, S Bobo Tanner, Harold Rosen, and Christopher Shuhart
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)., Iain B McInnes, Akihiko Asahina, Laura C Coates, Robert Landewé, Joseph F Merola, Christopher T Ritchlin, Yoshiya Tanaka, Laure Gossec, Alice B Gottlieb, Richard B Warren, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, and Philip Mease
Efficacy of Guselkumab on Axial-Related Symptoms Through up to 2 Years in Adults with Active Psoriatic Arthritis in the Phase 3, Randomized, Placebo-Controlled DISCOVER-2 Study., Philip Mease, Dafna D Gladman, Denis Poddubnyy, Soumya D Chakravarty, May Shawi, Alexa P Kollmeier, Xie L Xu, Stephen Xu, Atul Deodhar, and Xenofon Baraliakos
Earlier clinical response predicts low rates of radiographic progression in biologic-naïve patients with active psoriatic arthritis receiving guselkumab treatment., Philip Mease, Alice B Gottlieb, Alexis Ogdie, Iain B McInnes, Soumya D Chakravarty, Emmanouil Rampakakis, Alexa Kollmeier, Xie L Xu, May Shawi, Frederic Lavie, Mitsumasa Kishimoto, and Proton Rahman
Efficacy and Safety of Tyrosine Kinase 2/Janus Kinase 1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb Randomized Controlled Trial., Philip Mease, Philip Helliwell, Paula Silwinska-Stanczyk, Malgorzata Miakisz, Andrew Ostor, Elena Peeva, Michael S Vincent, Qiankun Sun, Vanja Sikirica, Randall Winnette, Ruolun Qiu, Gang Li, Gang Feng, Jean S Beebe, and David A Martin
Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet's Syndrome., Philip J Mease, Gülen Hatemi, Maria Paris, Sue Cheng, Peter Maes, Wendy Zhang, Rebecca Shi, Andrea Flower, Hernan Picard, and Linda Stein Gold
Real-World Evidence Assessing Psoriatic Arthritis by Disease Domain: An Evaluation of the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry., Philip J Mease, Jacqueline O'Brien, Nicole Middaugh, Gregory Kricorian, Scott Stryker, David H Collier, and Alexis Ogdie
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry., Philip J Mease, Alexis Ogdie, John Tesser, Natalie J Shiff, Iris Lin, Soumya D Chakravarty, Michael Kelleman, Rhiannon Dodge, Robert R McLean, Aaron Broadwell, Arthur Kavanaugh, and Joseph F Merola
Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies., Philip J Mease, Ana-Maria Orbai, Oliver FitzGerald, Mohamed Bedaiwi, Dona L Fleishaker, Rajiv Mundayat, Pamela Young, and Philip S Helliwell
Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis., Philip Mease, Peter Nash, Suzanne Grieb, and Vinod Chandran
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study., Philip Mease, Arathi Setty, Kim Papp, Filip Van den Bosch, Shigeyoshi Tsuji, Mauro Keiserman, Kyle Carter, Yihan Li, Reva McCaskill, Erin McDearmon-Blondell, Peter Wung, and William Tillett
